Company

Cyclopharm Limited

Headquarters: Kingsgrove, NSW, Australia

Employees: 53

CEO: Mr. James S. McBrayer F.A.C.I.D., BSPharm, GDM, FAICD, AIM

ASX: CYC +2.22%

Market Cap

A$186.1 Million

AUD as of July 1, 2024

US$124.0 Million

Market Cap History

Cyclopharm Limited market capitalization over time

Evolution of Cyclopharm Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Cyclopharm Limited

Detailed Description

Cyclopharm Limited engages in the research and development, manufacture, and sale of medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes third party products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. It serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Cyclopharm Limited has the following listings and related stock indices.


Stock: ASX: CYC wb_incandescent

Details

Headquarters:

1 The Crescent

Unit 4

Kingsgrove, NSW 2208

Australia

Phone: 61 2 9541 0411

Fax: 61 2 9543 0960